ALHYG.PA
Price:
$0.0103
Market Cap:
$3.95M
Hybrigenics SA, together with its subsidiaries, operates as a biotechnology company in France. The company engages in development of biotechnology in the field of biotechnology, oncology, regenerative medicine, and anti-aging medicine. It is also involved in the development of technical solutions using adipose tissue cells and stem cells. The company is headquartered in Gallargues-le-Montueux, France. Hybrigenics SA is a subsidiary of Diagnostic Medical Systems S.A.[Read more]
Industry
Biotechnology
IPO Date
2007-12-28
Stock Exchange
EURONEXT
Ticker
ALHYG.PA
According to Hybrigenics SA’s latest financial reports and current stock price. The company's current PE Ratio is -0.26. This represents a change of -40.72% compared to the average of -0.43 of the last 4 quarters.
The mean historical PE Ratio of Hybrigenics SA over the last ten years is -13.00. The current -0.26 PE Ratio has changed 98.13% with respect to the historical average. Over the past ten years (40 quarters), ALHYG.PA's PE Ratio was at its highest in in the December 2022 quarter at 2.58. The PE Ratio was at its lowest in in the June 2021 quarter at -125.15.
Average
-13.00
Median
-7.10
Minimum
-158.05
Maximum
116.34
Discovering the peaks and valleys of Hybrigenics SA PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 5.67%
Maximum Annual PE Ratio = 116.34
Minimum Annual Increase = -173.61%
Minimum Annual PE Ratio = -158.05
Year | PE Ratio | Change |
---|---|---|
2023 | -0.45 | -98.50% |
2022 | -30.02 | -125.80% |
2021 | 116.34 | -173.61% |
2020 | -158.05 | 521.60% |
2019 | -25.43 | 5.67% |
2018 | -0.44 | -85.82% |
2017 | -3.11 | -44.48% |
2016 | -5.60 | -34.87% |
2015 | -8.60 | -41.14% |
2014 | -14.61 | -32.58% |
The current PE Ratio of Hybrigenics SA (ALHYG.PA) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
28.62
5-year avg
-19.52
10-year avg
-13.00
Hybrigenics SA’s PE Ratio is greater than Neovacs S.A. (-0.28), less than Biophytis S.A. (-0.05), greater than Innate Pharma S.A. (-15.02), greater than Nanobiotix S.A. (-4.77), greater than Adocia SA (-2.29),
Company | PE Ratio | Market cap |
---|---|---|
-0.28 | $22.83K | |
-0.05 | $2.60M | |
-15.02 | $170.80M | |
-4.77 | $209.83M | |
-2.29 | $82.12M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hybrigenics SA using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hybrigenics SA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Hybrigenics SA's PE Ratio?
How is the PE Ratio calculated for Hybrigenics SA (ALHYG.PA)?
What is the highest PE Ratio for Hybrigenics SA (ALHYG.PA)?
What is the 3-year average PE Ratio for Hybrigenics SA (ALHYG.PA)?
What is the 5-year average PE Ratio for Hybrigenics SA (ALHYG.PA)?
How does the current PE Ratio for Hybrigenics SA (ALHYG.PA) compare to its historical average?